Ken Fisher acquired 80.7 Thousand Bio-Rad Laboratories - Ordinary Shares shares worth $28.2 Million. That's 0.01% of their equity portfolio (288th largest holding). The first Bio-Rad Laboratories - Ordinary Shares trade was made in Q1 2013. Since then Ken Fisher bought shares eight more times and sold shares on 35 occasions. The stake costed the investor $11.1 Million, netting the investor a gain of 154% so far.
Major players in the stem cell assay market are Thermo Fisher Scientific Inc. , Merck Group, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Labor...
GlobeNewswire, over 1 year agoThe Urinalysis Market report delivers a holistic analysis to understand the development scope and derive the growth rate for the forecast period. The report ...
Jumbo News, over 2 years agoMajor players in the liquid biopsy market are QIAGEN N. V. , Roche Diagnostics, Bio-Rad Laboratories Inc. , Myriad Genetics, Inc. , Guardant Health Inc. , Th...
Intrado Digital Media, over 2 years agoMajor players in the protein labeling market are Thermo Fisher Scientific Inc, Merck KGaA, PerkinElmer, Inc. , General Electric Company, F. Hoffmann-La Roche...
Intrado Digital Media, over 2 years ago